Lexaria Bioscience Corp. — Director's Dealing 2022

Oct 19, 2022

SEC Form 4/A — Form 4/A

Issuer: Lexaria Bioscience Corp. (LEXX)
CIK: 0001348362
Period of Report: 2022-10-14

Reporting Person: Downey Gregory (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-10-14	common shares	P	121	$2.09	Acquired	1954	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
common shares	1833	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options	$5.04	2026-04-15	Common Shares (4000)	4000	Direct
Stock Options	$5.04	2026-04-15	Common Shares (4000)	8000	Direct
Stock Options	$5.04	2026-04-15	Common Shares (4000)	12000	Direct
Stock Options	$5.31	2026-04-26	Common Shares (5000)	17000	Direct
Stock Options	$7.08	2026-06-08	Common Shares (8000)	25000	Direct
Stock Options	$6.23	2026-09-01	Common Shares (10000)	35000	Direct
Stock Options	$2.91	2027-08-29	Common Shares (11000)	46000	Direct

Footnotes

F1: This Form 4A is being filed to correct the transaction code for the open market purchase made by Mr. Downey as originally notated as a grant or award in the Form 4 filed on October 18, 2022.